Correlation Between Caribou Biosciences and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Caribou Biosciences and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and LMF Acquisition.
Diversification Opportunities for Caribou Biosciences and LMF Acquisition
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and LMF is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and LMF Acquisition go up and down completely randomly.
Pair Corralation between Caribou Biosciences and LMF Acquisition
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the LMF Acquisition. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 2.57 times less risky than LMF Acquisition. The stock trades about -0.15 of its potential returns per unit of risk. The LMF Acquisition Opportunities is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 2.72 in LMF Acquisition Opportunities on September 26, 2024 and sell it today you would lose (0.67) from holding LMF Acquisition Opportunities or give up 24.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. LMF Acquisition Opportunities
Performance |
Timeline |
Caribou Biosciences |
LMF Acquisition Oppo |
Caribou Biosciences and LMF Acquisition Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and LMF Acquisition
The main advantage of trading using opposite Caribou Biosciences and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
LMF Acquisition vs. Fate Therapeutics | LMF Acquisition vs. Caribou Biosciences | LMF Acquisition vs. Karyopharm Therapeutics | LMF Acquisition vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |